SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-002967
Filing Date
2021-01-11
Accepted
2021-01-11 16:06:16
Documents
15
Period of Report
2021-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm212739d2_8k.htm   iXBRL 8-K 25862
2 EXHIBIT 5.1 tm212739d2_ex5-1.htm EX-5.1 11366
3 GRAPHIC tm212739d2_ex5-1img001.jpg GRAPHIC 2192
4 GRAPHIC tm212739d2_ex5-1img002.jpg GRAPHIC 8204
  Complete submission text file 0001104659-21-002967.txt   227939

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA edit-20210105.xsd EX-101.SCH 3205
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE edit-20210105_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edit-20210105_pre.xml EX-101.PRE 22723
8 EXTRACTED XBRL INSTANCE DOCUMENT tm212739d2_8k_htm.xml XML 3490
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 21520869
SIC: 2836 Biological Products, (No Diagnostic Substances)